Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meilin Capsule for ureteral stent-related symptoms after upper urinary tract stone surgery
ChiCTR2300070249Phase 4Completed
- Sponsor
- Xiyuan Hospital
- Start
- May 2023
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Meilin in Lithiasis (2 arms), sponsored by Xiyuan Hospital. Primary endpoint: Ureteral stent symptom score. Started May 2023; status: completed.
02
Drugs
Meilin
03
Conditions
Lithiasis
Beyond the preview
Go deeper on ChiCTR2300070249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300070249.